Skip to main content

CORRECTION article

Front. Oncol., 09 February 2022
Sec. Thoracic Oncology

Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors

Paul Takam KamgaPaul Takam Kamga1Aurlie Swalduz,Aurélie Swalduz2,3Adrien Costantini,Adrien Costantini1,4Catherine Juli,Catherine Julié1,5Jean-Franois EmileJean-François Emile1Maurice ProlMaurice Pérol2Virginie AvrillonVirginie Avrillon3Sandra Ortiz-CuaranSandra Ortiz-Cuaran3Pierre De Saintigny,Pierre De Saintigny2,3Etienne Giroux-Leprieur,*Etienne Giroux-Leprieur1,4*
  • 1Université Paris-Saclay, UVSQ, EA 4340 BECCOH, Boulogne-Billancourt, France
  • 2Department of Medical Oncology, Centre Léon Bérard, Lyon, France
  • 3Univ Lyon, Université Claude Bernard Lyon 1, INSERM 1052, CNRS 5286, Centre Léon Bérard, Centre de Recherche en Cancérologie de Lyon, Lyon, France
  • 4Department of Respiratory Diseases and Thoracic Oncology, APHP – Hopital Ambroise Pare, Boulogne-Billancourt, France
  • 5Department of Pathology, APHP – Hopital Ambroise Pare, Boulogne-Billancourt, France

A Corrigendum on
High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors

By Takam Kamga P, Swalduz A, Costantini A, Julié C, Emile J-F, Pérol M, Avrillon V, Ortiz-Cuaran S, de Saintigny P and Giroux-Leprieur E (2021). Front. Oncol. 11:747692. doi: 10.3389/fonc.2021.747692

An author name was incorrectly spelled as Etienne Giroux LEPRIEUR. The correct spelling is Etienne GIROUX-LEPRIEUR.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: non-small cell lung cancer (NSCLC), epidermal growth factor receptor (EGFR), Sonic Hedgehog (Shh), biomarker, tyrosine kinase inhibitor (TKI)

Citation: Takam Kamga P, Swalduz A, Costantini A, Julié C, Emile J-F, Pérol M, Avrillon V, Ortiz-Cuaran S, De Saintigny P and Giroux-Leprieur E (2022) Corrigendum: High Circulating Sonic Hedgehog Protein Is Associated With Poor Outcome in EGFR-Mutated Advanced NSCLC Treated With Tyrosine Kinase Inhibitors. Front. Oncol. 12:852540. doi: 10.3389/fonc.2022.852540

Received: 11 January 2022; Accepted: 20 January 2022;
Published: 09 February 2022.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2022 Takam Kamga, Swalduz, Costantini, Julié, Emile, Pérol, Avrillon, Ortiz-Cuaran, De Saintigny and Giroux-Leprieur. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Etienne Giroux-Leprieur, Etienne.giroux-leprieur@aphp.fr

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.